The Max Foundation shared a post on LinkedIn:
“Together with our partners and supporters, we’re proving that geography should not determine destiny. Our 2024 Annual Report highlights this through:
- 84 countries reached with treatment and support programs
- Nearly 10 million daily doses of breakthrough medication delivered
- 4,240 new patients began receiving treatment for the first time
- 9,936 diagnostic tests provided across 38 countries
- 938 partners collaborated to drive health equity forward
You can read the full report here.”
More posts featuring The Max Foundation on OncoDaily.